Want to see IN:BIOCON full AI Analyst Report?
Total Valuation
Biocon Limited has a market cap or net worth of ₹667.53B. The enterprise value is ₹828.93K.
Market Cap₹667.53B
Enterprise Value₹828.93K
Share Statistics
Biocon Limited has 1,629,694,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,629,694,100
Owned by Insiders―
Owned by Institutions0.05%
Financial Efficiency
Biocon Limited’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 2.30%.
Return on Equity (ROE)0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)2.30%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee10.29M
Profits Per Employee234.45K
Employee Count16,447
Asset Turnover0.27
Inventory Turnover1.81
Valuation Ratios
The current PE Ratio of Biocon Limited is 120.4. Biocon Limited’s PEG ratio is -1.92.
PE Ratio120.4
PS Ratio2.92
PB Ratio1.45
Price to Fair Value1.45
Price to FCF-94.66
Price to Operating Cash Flow84.22
PEG Ratio-1.92
Income Statement
In the last 12 months, Biocon Limited had revenue of 169.27B and earned 3.86B in profits. Earnings per share was 2.82.
Revenue169.27B
Gross Profit58.85B
Operating Income14.99B
Pretax Income4.48B
Net Income3.86B
EBITDA33.95B
Earnings Per Share (EPS)2.82
Cash Flow
In the last 12 months, operating cash flow was 8.03B and capital expenditures -8.61B, giving a free cash flow of -575.00M billion.
Operating Cash Flow8.03B
Free Cash Flow-575.00M
Free Cash Flow per Share-0.35
Dividends & Yields
Biocon Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.12%
Dividend Per Share₹0.5
Dividend Yield0.12%
Payout Ratio15.80%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change15.75%
50-Day Moving Average422.63
200-Day Moving Average395.00
Relative Strength Index (RSI)38.93
Average Volume (3m)208.50K
Important Dates
Biocon Limited upcoming earnings date is Nov 5, 2026, TBA (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 5, 2026
Ex-Dividend Date―
Financial Position
Biocon Limited as a current ratio of 1.22, with Debt / Equity ratio of 44.14%
Current Ratio1.22
Quick Ratio0.79
Debt to Market Cap0.30
Net Debt to EBITDA3.61
Interest Coverage Ratio1.51
Taxes
In the past 12 months, Biocon Limited has paid 791.00M in taxes.
Income Tax791.00M
Effective Tax Rate0.18
Enterprise Valuation
Biocon Limited EV to EBITDA ratio is 18.14, with an EV/FCF ratio of -118.15.
EV to Sales3.64
EV to EBITDA18.14
EV to Free Cash Flow-118.15
EV to Operating Cash Flow48.24
Balance Sheet
Biocon Limited has ₹28.33B in cash and marketable securities with ₹155.51B in debt, giving a net cash position of -₹127.18B billion.
Cash & Marketable Securities₹28.33B
Total Debt₹155.51B
Net Cash-₹127.18B
Net Cash Per Share-₹78.04
Tangible Book Value Per Share₹57.13
Margins
Gross margin is 42.36%, with operating margin of 8.85%, and net profit margin of 2.28%.
Gross Margin42.36%
Operating Margin8.85%
Pretax Margin2.65%
Net Profit Margin2.28%
EBITDA Margin20.06%
EBIT Margin8.50%
Analyst Forecast
The average price target for Biocon Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.83%
EPS Growth Forecast5.07%